Abnormal gut microbiota composition contributes to cognitive dysfunction in streptozotocin-induced diabetic mice.
|
| Abstract |
Both diabetes and Alzheimer's disease are age-related disorders, and numerous studies have demonstrated that patients with diabetes are at an increased risk of cognitive dysfunction (CD) and Alzheimer's disease, suggesting shared or interacting pathomechanisms. The present study investigated the role of abnormal gut microbiota in diabetes-induced CD and the potential underlying mechanisms. An intraperitoneal injection of streptozotocin administered for 5 consecutive days was used for establishing a diabetic animal model. Hierarchical cluster analysis of Morris water maze (MWM) performance indices (escape latency and target quadrant crossing) was adopted to classify the diabetic model mice into CD and Non-CD phenotypes. Both β-diversity and relative abundance of several gut bacteria significantly differed between the CD and Non-CD groups. Further, fecal bacteria transplantation from Non-CD mice, but not from CD mice, into the gut of pseudo-germ-free mice significantly improved host MWM performance, an effect associated with alterations in β-diversity and relative abundance of host gut bacteria. Collectively, these findings suggest that abnormal gut microbiota composition contributes to the onset of diabetes-induced CD and that improving gut microbiota composition is a potential therapeutic strategy for diabetes and related comorbidities.
|
|---|---|
| Authors | Fan Yu, Wei Han, Gaofeng Zhan, Shan Li, Shoukui Xiang, Bin Zhu, Xiaohong Jiang, Ling Yang, Ailin Luo, Fei Hua, Chun Yang |
| Journal | Aging (Aging (Albany NY)) Vol. 11 Issue 10 Pg. 3262-3279 (05 23 2019) ISSN: 1945-4589 [Electronic] United States |
| PMID | 31123221 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't) |
| Chemical References |
|
| Topics |
|
Join CureHunter, for free Research Interface BASIC access!
Realize the full power of the drug-disease research graph!